Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialW. Timothy Garvey, Anuj Bhargava, Juan P. Frías et al.|The Lancet|2023Cited by 676
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal InsulinThomas W. Martens, Amy Change, Rodica Pop‐Busui et al.|JAMA|2021Cited by 491
A comprehensive review on catalytic etherification of glycerol to value-added productsAnuj Bhargava, Manishkumar S. Tiwari, Shraddha Shelke et al.|Reviews in Chemical Engineering|2022Cited by 12